Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

49.55
-0.4000-0.80%
Pre-market: 49.20-0.3500-0.71%04:27 EDT
Volume:806.72K
Turnover:39.91M
Market Cap:3.91B
PE:-10.48
High:50.39
Open:50.03
Low:48.86
Close:49.95
Loading ...

PTC Therapeutics : Disappointed That After Prolonged Period of Review European Commission Has Decided to Adopt Chmp Negative Opinion on Translarna

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Provides Regulatory Update on Translarna™ (Ataluren) in Europe

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Inc: Look Forward to Working on a Country-by-Country Basis to Provide Commercial Drug Where Possible

THOMSON REUTERS
·
28 Mar

PTC Therapeutics Inc: This Action Effectively Removes Drug's Conditional Marketing Authorization in European Economic Area

THOMSON REUTERS
·
28 Mar

How to Play SRPT Stock After Patient Death Post DMD Therapy Infusion

Zacks
·
24 Mar

Promising Potential of PTC Therapeutics’ Sepiapterin in PKU Treatment Justifies Buy Rating

TIPRANKS
·
21 Mar

PTC Therapeutics Inc - Presents New Data From Phase 3 Aphenity Trial

THOMSON REUTERS
·
20 Mar

PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies

PR Newswire
·
20 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Washington Trust, Centessa Pharma, Kingstone

Reuters
·
15 Mar

BUZZ-PTC Therapeutics rises as J.P.Morgan raises PT on potential drug launches

Reuters
·
14 Mar

PTC Therapeutics Inc : JP Morgan Raises Target Price to $78 From $72

THOMSON REUTERS
·
14 Mar

Citi says SMid biotechs alternative to large caps as it starts coverage

Investing.com
·
13 Mar

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

Reuters
·
13 Mar

PTC Therapeutics Inc : Citigroup Raises Target Price to $50 From $46

THOMSON REUTERS
·
13 Mar

PTC Therapeutics Raised to Neutral From Underperform by B of A Securities

Dow Jones
·
11 Mar

PTC Therapeutics upgraded to Neutral from Underperform at BofA

TIPRANKS
·
11 Mar

PTC Therapeutics Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)

TIPRANKS
·
07 Mar

Analysts Conflicted on These Healthcare Names: PTC Therapeutics (PTCT), 4D Molecular Therapeutics (FDMT) and Biohaven Ltd. (BHVN)

TIPRANKS
·
05 Mar

Kiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock?

Zacks
·
04 Mar